期刊文献+

阴沟肠杆菌质粒介导耐喹诺酮类药物的机制研究

Plasmid-mediated quinolone resistance in clinical isolates of Enterobacter cloacae
暂未订购
导出
摘要 目的 了解深圳地区阴沟肠杆菌中qnrA基因的流行情况、基因定位及其介导喹诺酮耐药性产生的机制。方法 收集临床分离的阴沟肠杆菌45株,采用PCR法结合测序的技术筛查qnrA基因,大质粒提取技术、Southern杂交和接合传递试验进行质粒定位,琼脂对倍稀释法进行药物敏感性检测。结果45株阴沟肠杆菌中,7株PCR法及测序证实为qnrA基因。7株菌中6株菌所携质粒被成功提取并进行Southern杂交,qnrA基因定位于80~200kb大小的低拷贝数天然质粒上。4株菌成功进行接合传递试验,使接合子对环丙沙星的MIC值提高了32-64倍。结论 质粒介导的喹诺酮耐药基因qnrA在深圳地区阴沟肠杆菌中具有较高的流行率,可能是导致阴沟肠杆菌对喹诺酮类抗菌药获得性耐药的重要原因。 Objective To investigate the prevalence and location of qnrA gene in clinical isolates of Enterobacter cloacae and its function in the development of quinolone resistance. Method Forty-five Enterobacter cloacae were screened for the qnrA gene by PCR and then conformed with direct sequencing. Large plasmid extraction and Southern hybridization were done to determine the location of qnrA. Conjugation experiments were done to determine the transferability and its effects in the development of quinolone resistance. Results qnrA were detected in 7 (15.6%) of 45 strains. The qnrA sequence matched that of NCBI GenBank with 100%. Plasmid extraction and Southern hybridization succeed in 6 stains. The qnrA were located in plasmids in size of 80-200kb. Conjugation experiments were done in 4 strains. Transconjugants had 32-64-fold increases in the MIC of ciprofloxacin compared with that of the recipient but were still susceptible to ciprofloxacin according to CLSI stardard. Conclusion Transferable plasmid-mediated quinolone resistance associated with qnrA were high prevalent in clinical isolates of Enterobacter cloacae from Shenzhen city and may contribute to the quinolone resistance of these bacteria.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第9期569-571,共3页 Chinese Journal of Antibiotics
基金 广东省自然科学基金(No.5009113) 深圳市科技计划(No.200602158)共同资助
关键词 qnrA基因 阴沟肠杆菌 喹诺酮 耐药 质粒 qnrA Enterobacter cloacae Quinolone Drug resistance Plasmid
  • 相关文献

参考文献11

  • 1Martinez-Martinez L,Pascual A,Jacoby G A.Quinolone resistance from a transferable plasmid[J].Lancet,1998,351(9105):797-799.
  • 2Wang M,Tran J H,Jacoby G A,et al.Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai,China [J].Antimicrob Agents Chemother,2003,47(7):2242-2248.
  • 3李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 4周光,沈定霞,罗燕萍,管希周.临床阴沟肠杆菌感染的分布与耐药特性研究[J].中华医院感染学杂志,2006,16(3):340-342. 被引量:27
  • 5陈晓玲.阴沟肠杆菌耐药机制的研究进展[J].中国抗感染化疗杂志,2005,5(5):310-313. 被引量:21
  • 6潘晓娴,唐英春,廖康,张永.质粒介导的克雷伯菌耐喹诺酮类药物机制研究[J].中国抗生素杂志,2006,31(5):295-297. 被引量:19
  • 7Tran J H,Jacoby G A.Mechanism of plasmid-mediated quinolone resistance[J].Proc Natl Acad Sci USA,2002,99(8):5638-5642.
  • 8Tran J H,Jacoby G A,Hooper D C.Interaction of the plasmid encoded quinolone resistance protein Qnr with EscheHchia coli DNA gyrase[J].Antimicrob Agents Chemother,2005,49(1):118-125.
  • 9Corkill J E,Anson J J,Hart C A.High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool,UK[J].J Antimicrob Chemother.2005,56(6):1115-1117.
  • 10Robicsek A,Sahm D F,Strahilevitz J.et al.Broader distribution of plasmid-mediated quinolone resistance in the United States[J].Antimicrob Agents Chemother,2005,49(7):3001-3003

二级参考文献41

  • 1顾怡明,张杰,俞云松,周志慧,杜小玲.多重耐药阴沟肠杆菌流行状况及耐药机制的研究[J].中华医院感染学杂志,2004,14(12):1321-1324. 被引量:63
  • 2李艳,刘长庭.阴沟肠杆菌AmpC酶检测及对酶抑制剂复合制剂稳定性研究[J].中华医院感染学杂志,2005,15(1):17-19. 被引量:15
  • 3李庆,王同志,裴怀腾.阴沟肠杆菌AmpC酶检测和对14种抗生素的耐药性研究[J].中国卫生检验杂志,2004,14(6):752-753. 被引量:2
  • 4李介华,苏丹,袁春雷.阴沟肠杆菌产诱导型β内酰胺酶及耐药性分析[J].中国公共卫生,2005,21(2):226-227. 被引量:7
  • 5National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
  • 6Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
  • 7Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
  • 8Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
  • 9Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.
  • 10Trepanier S, Knox JR, Clairoux N, et al. Structure-function studies of ser-289 in the class C beta-lactamase from Enterobacter cloacae P99 [ J]. Antimicrob Agents Chemother,1999,43: 543-548.

共引文献356

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部